The current investigation furnishes an empirical foundation for the novel molecularly targeted α-methylchalcone derivatives, which are predicated on tubulin/P-gp targets, in terms of their efficacy against multidrug-resistant cervical cancer (Figure 2). This evidence concerns the gene PGP and cervical carcinoma.